Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001213900-25-022445
Filing Date
2025-03-11
Accepted
2025-03-11 07:45:27
Documents
2

Document Format Files

Seq Description Document Type Size
1 SOLICITING MATERIAL UNDER 240.14A-12 ea0233917-defa14a_optimizerx.htm DEFA14A 30973
2 GRAPHIC image_001.jpg GRAPHIC 4910
  Complete submission text file 0001213900-25-022445.txt   38907
Mailing Address 260 CHARLES STREET SUITE 302 WALTHAM MA 02453
Business Address 260 CHARLES STREET SUITE 302 WALTHAM MA 02453 248-651-6558
OptimizeRx Corp (Filer) CIK: 0001448431 (see all company filings)

EIN.: 261265381 | State of Incorp.: NV | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-38543 | Film No.: 25725880
SIC: 7389 Services-Business Services, NEC
(CF Office: 07 Trade & Services)